Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence)

Renal Cancer Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02295982
• Other study ID #: SJ-416
• Status: Completed
• Phase: N/A
• First received: November 17, 2014
• Last updated: January 22, 2018
• Start date: November 2014
• Est. completion date: May 2016

Study information

• Verified date: January 2018
• Source: Zealand University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to describe the postoperative outcomes after laparoscopic transperitoneal nephrectomy and compare them with hand assisted laparoscopic nephrectomy with a focus on the limiting factors that prevent an ambulatory nephrectomy, and the benefit of our experiences from the previous study to optimize the postoperative outcomes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: May 2016
• Est. primary completion date: May 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 25 Years to 75 Years

Eligibility

Inclusion criteria:

1. Patient between 25-80 years old.

2. Diagnosed as Cancer Renis

3. Can read and understand Danish

4. No cardiac disease lead to close cardiologic observations

5. Any T, any N any M stadia.

Exclusion criteria:

1. Mentally sick patient

2. Dement

3. Living alone

4. Cardiac problem

5. Per operative bleeding with the need to blood transfusion

6. Operation time at afternoon

Related Conditions & MeSH terms

• Carcinoma, Renal Cell
• Kidney Neoplasms
• Renal Cancer

Intervention

Procedure:
• Hand assisted laparoscopic nephrectomy
patients with renal cancer will undergo hans assisted laparoscopic nephrectomy

Locations

Country	Name	City	State
Denmark	Roskilde Hospital	Roskilde

Sponsors (1)

Lead Sponsor	Collaborator
Zealand University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative hospital admission		one day